Your browser doesn't support javascript.
loading
Protocol of a randomized controlled trial investigating the effectiveness of Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS).
Cadilhac, Dominique A; Cameron, Jan; Kilkenny, Monique F; Andrew, Nadine E; Harris, Dawn; Ellery, Fiona; Thrift, Amanda G; Purvis, Tara; Kneebone, Ian; Dewey, Helen; Drummond, Avril; Hackett, Maree; Grimley, Rohan; Middleton, Sandy; Thijs, Vincent; Cloud, Geoffrey; Carey, Mariko; Butler, Ernest; Ma, Henry; Churilov, Leonid; Hankey, Graeme J; English, Coralie; Lannin, Natasha A.
Afiliação
  • Cadilhac DA; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.
  • Cameron J; Stroke theme, Florey Institute of Neuroscience and Mental Health, Heidelberg, Australia.
  • Kilkenny MF; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.
  • Andrew NE; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.
  • Harris D; Stroke theme, Florey Institute of Neuroscience and Mental Health, Heidelberg, Australia.
  • Ellery F; Peninsula Clinical School, Central Clinical School, Monash University, Clayton, Australia.
  • Thrift AG; Professorial Academic Unit, Frankston Hospital, Peninsula Health, Frankston, Australia.
  • Purvis T; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.
  • Kneebone I; Stroke theme, Florey Institute of Neuroscience and Mental Health, Heidelberg, Australia.
  • Dewey H; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.
  • Drummond A; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.
  • Hackett M; Graduate School of Health, University of Technology Sydney, Ultimo, Australia.
  • Grimley R; Eastern Health Clinical School, Monash University, Clayton, Australia.
  • Middleton S; Department of Neurosciences, Eastern Health, Box Hill, Australia.
  • Thijs V; Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
  • Cloud G; The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australia.
  • Carey M; Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.
  • Butler E; Sunshine Coast Clinical School, Griffith University, Birtinya, Australia.
  • Ma H; Nursing Research Institute, St Vincent's Health Network, Sydney, Australia.
  • Churilov L; Nursing Research Institute, Australian Catholic University, Sydney, Australia.
  • Hankey GJ; Stroke theme, Florey Institute of Neuroscience and Mental Health, Heidelberg, Australia.
  • English C; Department of Neurology, Austin Health, Heidelberg, Australia.
  • Lannin NA; Department of Neurology, Alfred Health, Melbourne, Australia.
Int J Stroke ; 17(2): 236-241, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34037468
RATIONALE: To address unmet needs, electronic messages to support person-centered goal attainment and secondary prevention may avoid hospital presentations/readmissions after stroke, but evidence is limited. HYPOTHESIS: Compared to control participants, there will be a 10% lower proportion of intervention participants who represent to hospital (emergency/admission) within 90 days of randomization. METHODS AND DESIGN: Multicenter, double-blind, randomized controlled trial with intention-to-treat analysis. The intervention group receives 12 weeks of personalized, goal-centered, and administrative electronic messages, while the control group only receive administrative messages. The trial includes a process evaluation, assessment of treatment fidelity, and an economic evaluation. Participants: Confirmed stroke (modified Rankin Score: 0-4), aged ≥18 years with internet/mobile phone access, discharged directly home from hospital. Randomization: 1:1 computer-generated, stratified by age and baseline disability. Outcomes assessments: Collected at 90 days and 12 months following randomization. OUTCOMES: Primary outcomes include hospital emergency presentations/admissions within 90 days of randomization. Secondary outcomes include goal attainment, self-efficacy, mood, unmet needs, disability, quality-of-life, recurrent stroke/cardiovascular events/deaths at 90 days and 12 months, and death and cost-effectiveness at 12 months. Sample size: To test our primary hypothesis, we estimated a sample size of 890 participants (445 per group) with 80% power and two-tailed significance threshold of α = 0.05. Given uncertainty for the effect size of this novel intervention, the sample size will be adaptively re-estimated when outcomes for n = 668 are obtained, with maximum sample capped at 1100. DISCUSSION: We will provide new evidence on the potential effectiveness, implementation, and cost-effectiveness of a tailored eHealth intervention for survivors of stroke.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / COVID-19 Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Adolescent / Adult / Humans Idioma: En Revista: Int J Stroke Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / COVID-19 Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Adolescent / Adult / Humans Idioma: En Revista: Int J Stroke Ano de publicação: 2022 Tipo de documento: Article